Zevra Therapeutics, Inc. (ZVRA)

NASDAQ: ZVRA · Real-Time Price · USD

10.53

-0.64 (-5.73%)

At close: Nov 5, 2026, 4:00 PM EST

10.52

-0.01 (-0.09%)

After-hours: Nov 5, 2026, 7:30 PM EST

Zevra Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	147.76	106.47	23.61	27.46	10.16	28.65
Revenue Growth	75.10%	350.92%	-14.02%	170.26%	-64.53%	115.61%
Gross Profit	141.03	89.99	16.2	25.29	9.94	26.59
Operating Income	46.5	-4.23	-87	-49.6	-24.9	7.73
Net Income	74.97	77.59	-105.51	-46.05	-26.77	-62.9
Earnings Per Share	1.23	1.35	-2.28	-1.30	-0.78	-2.11
EPS Growth	128.31%	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	195.57	191.01	69.5	67.74	82.85	112.35
Total Debt	1.23	63.21	60.3	43.77	14.13	1.61
Net Cash (Debt)	194.34	127.81	9.2	23.97	68.72	110.74
Net Cash Growth	42.07%	1289.18%	-61.62%	-65.11%	-37.95%	-
Net Cash Per Share	3.21	2.23	0.20	0.68	1.99	3.72

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	38.74	-1.6	-69.67	-33.54	-18.72	10.44
Capital Expenditures	-0.46	-0.84	-	-0.3	-0.09	-0.1
Free Cash Flow	38.28	-2.43	-69.67	-33.83	-18.81	10.34
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	95.44%	84.52%	68.59%	92.09%	97.81%	92.81%
Operating Margin	31.47%	-3.98%	-368.47%	-180.63%	-245.07%	26.98%
Pretax Margin	60.90%	81.41%	-381.76%	-167.69%	-263.80%	-29.74%
Profit Margin	50.74%	72.87%	-446.85%	-167.69%	-263.48%	-219.54%
FCF Margin	25.91%	-2.28%	-295.04%	-123.20%	-185.12%	36.08%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	8.57	6.50	-	-	-	-
Forward PE	10.59	19.15	102.50	102.50	102.50	24.17
P/FCF Ratio	16.40	-	-	-	-	29.76
PS Ratio	4.25	4.74	18.85	9.90	15.59	10.74